Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Driving cancer evolution.

Devon M Fitzgerald1,2,3,4, Susan M Rosenberg1,2,3,4

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.

Elife
|March 11, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

H2AX C-Terminal Dipeptide Truncation: A Master Switch of the DNA Damage Response.

bioRxiv : the preprint server for biology·2026
Same author

Endogenous DNA damage at sites of terminated transcripts.

Nature·2025
Same author

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.

Nature reviews. Cancer·2024
Same author

Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2024
Same author

Life, the genome and everything.

Journal of bacteriology·2023
Same author

Drugging evolution of antibiotic resistance at a regulatory network hub.

Science advances·2023

Tumor growth factor-beta signaling promotes cancer drug resistance by hindering accurate DNA repair mechanisms. This pathway allows cancer cells to survive and adapt, leading to treatment failure.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Tumor growth factor-beta (TGF-β) is a key regulator in cellular processes.
  • Dysregulation of TGF-β signaling is implicated in cancer progression and drug resistance.
  • Accurate DNA repair is crucial for maintaining genomic stability and preventing cancer development.

Purpose of the Study:

  • To investigate the role of TGF-β signaling in the development of cancer drug resistance.
  • To elucidate the mechanisms by which TGF-β signaling impacts DNA repair pathways in cancer cells.

Main Methods:

  • Analysis of TGF-β signaling pathway components in cancer cell lines.
  • Assessment of DNA repair gene expression and activity under TGF-β stimulation.
  • Drug sensitivity assays in cancer cells with modulated TGF-β signaling.
Keywords:
cancer biologycell biologycopy number alterationdrug adaptabilitygenetic diversityhumanintra-tumor heterogeneitytumor evolutiontumor fitness

Related Experiment Videos

Main Results:

  • TGF-β signaling was found to down-regulate the expression and activity of key DNA repair proteins.
  • Inhibition of DNA repair by TGF-β signaling correlated with increased resistance to chemotherapeutic agents.
  • Cancer cells with activated TGF-β pathways exhibited impaired homologous recombination and other DNA repair mechanisms.

Conclusions:

  • TGF-β signaling is a critical mediator of drug resistance in cancer.
  • Targeting TGF-β signaling may represent a therapeutic strategy to overcome drug resistance by restoring DNA repair fidelity.